
Xinguang Pharma's shareholder, Feng Investment, plans to reduce its holdings by no more than 3%

I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Xinguang Pharma announced that its shareholder, Shengzhou Hefeng Investment Co., Ltd. ("Hefeng Investment"), plans to reduce its holdings of no more than 4.8 million shares of the company (i.e., no more than 3% of the company's total share capital) through centralized bidding or block trading within 3 months after 15 trading days from the date of this announcement
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

